To include your compound in the COVID-19 Resource Center, submit it here.

Adventrx Pharmaceuticals Inc, SynthRx Inc. deal

Adventrx completed its previously announced acquisition of

Read the full 77 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE